ZIMMER BIOMET HOLDINGS, INC. (ZBH)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
---|---|---|---|---|
Net sales | 2,077,300 | 1,909,100 | 1,824,200 | 1,942,000 |
Restructuring and other cost reduction initiatives | 17,500 | 36,000 | 32,200 | 41,500 |
Acquisition, integration, divestiture and related | 78,900 | 10,600 | 4,400 | 5,200 |
Selling, general and administrative | 814,800 | 758,800 | 709,700 | 737,100 |
Research and development | 113,300 | 110,600 | 111,600 | 109,400 |
Cost of products sold, excluding intangible asset amortization | 592,200 | 549,800 | 538,600 | 553,600 |
Intangible asset amortization | 160,600 | 151,000 | 148,200 | 144,000 |
Operating expenses | 1,777,300 | 1,616,800 | 1,544,700 | 1,590,800 |
Operating profit | 300,000 | 292,300 | 279,500 | 351,300 |
Interest expense, net | -79,300 | -66,200 | -54,300 | -51,100 |
Other income, net | 3,900 | 2,900 | 5,100 | 2,000 |
Earnings before income taxes | 224,600 | 229,000 | 230,300 | 302,200 |
Provision for income taxes | 71,200 | 46,500 | -18,900 | 59,100 |
Net earnings | 153,400 | 182,600 | 249,200 | 243,100 |
Less net earnings attributable to noncontrolling interest | 600 | 600 | 200 | 300 |
Net earnings of zimmer biomet holdings, inc | 152,800 | 182,000 | 249,100 | 242,800 |
Net earnings per common share - basic | 0.77 | 0.92 | 1.23 | 1.18 |
Net earnings per common share - diluted | 0.77 | 0.91 | 1.23 | 1.18 |
Weighted average number of shares outstanding, basic, total | 197,900,000 | 198,900,000 | 202,300,000 | 205,700,000 |
Weighted average shares outstanding for diluted net earnings per share | 198,300,000 | 199,700,000 | 203,000,000 | 206,400,000 |